Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-06-03

FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved Sagent Pharmaceuticals' supplemental application for famotidine under an existing ANDA, updating the product's approved labeling. This action c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

SUPPL AP for FAMOTIDINE (FAMOTIDINE)